Literature DB >> 9426634

Involvement of Gly96 in the formation of the Rh26 epitope.

B H Faas1, P C Ligthart, C Lomas-Francis, M A Overbeeke, A E von dem Borne, C E van der Schoot.   

Abstract

BACKGROUND: The Rh system, a complex blood group system, comprises at least 45 antigens. Red cells expressing c usually express Rh26. Rare cells that are c+ Rh:-26 give variable reactions with anti-c and may have weak expression of f (ce). STUDY DESIGN AND METHODS: Serologic and molecular studies were performed with red cells from persons with the c+ Rh:-26 phenotype occurring in two unrelated Dutch families. Red cells of 11 members of these two families were typed for Rh26, for c (with monoclonal and polyclonal reagents), and for f (ce). The cDNA of three donors was sequenced, while restricted DNA analysis was carried out on material from available members of the two families.
RESULTS: Serologic tests showed that the rare c+ Rh:-26 phenotype was associated with a weak expression of c and a normal expression of f. The cDNA analysis of three members of one family revealed a single-point mutation (G286A) in exon 2 of the ce allele. Allele-specific primer amplification, polymerase chain reaction followed by allele-specific restriction analysis, and single-strand conformation polymorphism showed the same polymorphism in all other members of both families, whereas it was absent in 80 control donors.
CONCLUSION: The c+ Rh:-26 phenotype, identified in two families, is associated with a single-point mutation at nucleotide 286 (G286A) in the ce allele, which predicts a Gly96Ser amino acid substitution. This substitution also affects c, because all anti-c reagents reacted more weakly. Other polymorphic sites apparently are involved in the formation of the Rh26 epitope as well, because Rh26 is expressed only on the c polypeptide, whereas Gly96 is expressed on all polypeptides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426634     DOI: 10.1046/j.1537-2995.1997.37111298088040.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford.

Authors:  Christine Halter Hipsky; Christine Lomas-Francis; Akiko Fuchisawa; Marion E Reid; Marilyn Moulds; Joann Christensen; Pam Nickle; Sunitha Vege; Connie Westhoff
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

2.  Alloanti-c in a c-positive, JAL-positive patient.

Authors:  J Ong; P S Walker; E Schmulbach; J R Storry; S Vege; C Westhoff; C Lomas-Francis; M E Reid
Journal:  Vox Sang       Date:  2008-12-05       Impact factor: 2.144

3.  JAL (RH48) blood group antigen: serologic observations.

Authors:  Christine Lomas-Francis; Denden Alcantara; Connie Westhoff; Joan Uehlinger; Marilia Valvasori; Lillian Castilho; Marion E Reid
Journal:  Transfusion       Date:  2008-12-15       Impact factor: 3.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.